Prometheus Biosciences
RXDX
$199.92
Share price
0.00%
Change (1 day)
360.96%
Change (1 year)
Categories
Prometheus Biosciences (RXDX) - Cash on Hand
Cash on Hand as of March 2023 : $0.71 B
According to Prometheus Biosciences's latest financial reports the company has $0.71 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Prometheus Biosciences - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.69 B | 170.45% |
| 2021-12-31 | $0.25 B | 374.63% |
| 2020-12-31 | $54.2 M | 1118% |
| 2019-12-31 | $4.45 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Epizyme EPZM | N/A | N/A | 🇺🇸 USA |
 Akebia Therapeutics AKBA | $42.92 M | -93.99% | 🇺🇸 USA |
 Agenus
AGEN | $76.11 M | -89.34% | 🇺🇸 USA |